stock-detail (TKMR)

Oncology Corporate Profile

Company Description

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
TKM-PLK1polo-like kinase 1 (PLK1) inhibitorAdrenocortical carcinoma (ACC)II
TKM-PLK1polo-like kinase 1 (PLK1) inhibitorHepatocellular carcinoma (HCC)II
TKM-PLK1polo-like kinase 1 inibitorAdrenocortical carcinoma (ACC)I
TKM-PLK1polo-like kinase 1 inibitorGastrointestinal Stromal Tumors (GIST)I
TKM-PLK1polo-like kinase 1 inibitorHepatocellular carcinoma (HCC)I

Recent News Headlines

Spring Bank and Arbutus Biopharma Announce Preclinical Collaboration in Study of Chronic Hepatitis B

12/19/2016 12:00 pm

[GlobeNewswire] - HOPKINTON, Mass., Dec. 19, 2016-- Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, cancer, and inflammatory ...

Moderna's Mysterious Medicines

12/14/2016 11:05 am

Arbutus Provides Additional Data from the ARB-1467 Phase II Clinical Trial in HBV Patients

12/12/2016 09:00 pm

[GlobeNewswire] - Complete Cohort 1 and 2 ARB-1467 Multi-Dose Data Demonstrate Dose-Responsive HBsAg Reductions Greater Than 1.0 log 10 Reduction in Serum HBsAg Observed in 3/ 5 Patients After Receiving Three Monthly Doses ...